TY  - GEN
AU  - Bernardino,Jose I
AU  - Mocroft,Amanda
AU  - Mallon,Patrick W
AU  - Wallet,Cedrick
AU  - Gerstoft,Jan
AU  - Russell,Charlotte
AU  - Reiss,Peter
AU  - Katlama,Christine
AU  - De Wit,Stephane
AU  - Richert,Laura
AU  - Babiker,Abdel
AU  - Buño,Antonio
AU  - Castagna,Antonella
AU  - Girard,Pierre-Marie
AU  - Chene,Genevieve
AU  - Raffi,Francois
AU  - Arribas,Jose R
TI  - Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial
SN  - 2352-3018
PY  - 2016///0920
KW  - Absorptiometry, Photon
KW  - Adult
KW  - Anti-HIV Agents
KW  - administration & dosage
KW  - Biomarkers
KW  - blood
KW  - Bone Density
KW  - drug effects
KW  - Bone Diseases, Metabolic
KW  - chemically induced
KW  - CD4 Lymphocyte Count
KW  - Comorbidity
KW  - Darunavir
KW  - Drug Therapy, Combination
KW  - Emtricitabine
KW  - Europe
KW  - epidemiology
KW  - Female
KW  - HIV Infections
KW  - complications
KW  - Humans
KW  - Inflammation
KW  - physiopathology
KW  - Male
KW  - Middle Aged
KW  - Osteopetrosis
KW  - Raltegravir Potassium
KW  - Ritonavir
KW  - Tenofovir
KW  - Viral Load
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S2352-3018(15)00181-2
ER  -